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Abstract
Arsenic is a well-known human skin carcinogen but the underlying mechanisms of carcinogenesis
are unclear. Transcription factor Nrf2-mediated antioxidant response represents a critical cellular
defense mechanism, and emerging data suggest that constitutive activation of Nrf2 contributes to
malignant phenotype. In the present study when an immortalized, non-tumorigenic human
keratinocyte cell line (HaCaT) was continuously exposed to environmentally relevant level of
inorganic arsenite (100 nM) for 28 weeks, malignant transformation occurred as evidenced by the
formation of highly aggressive squamous cell carcinoma after inoculation into nude mice. To
investigate the mechanisms involved, a broad array of biomarkers for transformation were assessed
in these arsenic-transformed cells (termed As-TM). In addition to increased secretion of matrix
metalloproteinase-9 (MMP-9), a set of markers for squamous differentiation and skin keratinization,
including keratin-1, keratin-10, involucrin, and loricrin, were significantly elevated in As-TM cells.
Furthermore, As-TM cells showed increased intracellular glutathione, elevated expression of Nrf2
and its target genes, as well as generalized apoptotic resistance. In contrast to increased basal Nrf2
activity in As-TM cells, a diminished Nrf2-mediated antioxidant response induced by acute exposure
to high dose of arsenite or tert-butyl hydroxyquinone occurred. The findings that multiple biomarkers
for malignant transformation observed in As-TM cells, including MMP-9 and cytokeratins, are
potentially regulated by Nrf2 suggest constitutive Nrf2 activation may be involved in arsenic
carcinogenesis of skin. The weakened Nrf2 activation in response to oxidative stressors observed in
As-TM cells, coupled with acquired apoptotic resistance, would potentially have increased the
likelihood of transmittable oxidative DNA damage and fixation of mutational/DNA damage events.
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Introduction
Inorganic arsenic is a well-recognized, multi-site human carcinogen and exposure is associated
with an increased risk for dermal malignancies [1]. Arsenic is also carcinogenic in rodent
models, producing liver, lung, ovary and adrenal tumors after transplacental exposure [2] and
skin tumors in combination with ultraviolet (UV) irradiation or phorbol esters in mice [3,4].
However, arsenic alone does not appear to induce skin cancer in these mouse models [2–4],
suggesting events associated with arsenic-induced dermal carcinogenesis may be distinct from
other target tissues. Accumulating evidence suggests that oxidative stress occurs in response
to arsenic exposure [5,6] and may be one factor in dermal arsenic carcinogenesis. Indeed,
evidence of arsenic-induced oxidative DNA damage has been observed in cells [7–12], in
rodents [13] and in humans [14].
Transcription factor NF-E2-related factor 2 (Nrf2), a Cap‘n’ collar basic leucine zipper protein,
regulates critically important cellular defense transcriptional programs that maintain cellular
redox homeostasis and serve to limit oxidative damage and inflammation [15]. Nrf2 controls
expression of a variety of genes encoding for antioxidative and phase 2 drug-metabolizing
enzymes through antioxidant response elements (ARE) [15]. Nrf2-controlled genes encode for
various enzymes, including detoxification enzymes like glutathione S-transferases (GST),
NAD(P)H: quinone oxidoreductase 1 (NQO1), and heme oxygenase 1 (HO-1) and antioxidant
enzymes like the γ-glutamate cysteine ligase catalytic subunit (GCLC) and regulatory subunit
(GCLM). Nrf2 also controls expression of several transporters including the multidrug
resistance protein-1 and cysteine-glutamate-exchange transporter, among many other proteins.
Supporting the importance of Nrf2 in cellular defense is the finding that Nrf2-deficient mice
show a deficiency in this coordinated gene regulatory program and have a higher susceptibility
to both oxidative damage and chemical carcinogenesis [16,17]. In apparent contrast to
extensive data showing that low Nrf2 activity predisposes cells to chemical carcinogenesis,
emerging evidence suggests that constitutive activation of Nrf2 may contribute to a malignant
phenotype [18]. Indeed, increased expression and activity of Nrf2 has been observed in various
tumor cells [19,20]. These inconsistencies suggest that Nrf2 may play paradoxical roles in
different stages of tumorigenesis.
Given the potential importance of oxidative DNA damage in dermal carcinogenesis, as well
as the critical roles of Nrf2 in the defense against oxidative damage, here we study whether
Nrf2 and its target genes are involved in arsenic-induced skin carcinogenesis using a human




The HaCaT cell is a spontaneously immortalized human epithelial cell line developed by
Boukamp et al. [21]. The cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum, 100 U penicillin/ml, and 100 μg streptomycin/ml.
Cultures were maintained at 37°C in a humidified 5% CO2 atmosphere with an oxygen
concentration of 19.9%. For chronic arsenic exposure, cells were maintained continuously in
medium containing 100 nM of sodium arsenite (NaAsO2, Sigma, St. Louis, MO) for 28 weeks
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as described previously [10]. All the materials for cell culture were purchased from Invitrogen
(Carlsbad, CA)
Zymographic analysis of metalloproteinase-9 (MMP-9) activity
Cells at 70–80% confluence were washed twice with phosphate-buffered saline (PBS), and the
medium was changed to serum-free DMEM. After 48 hrs, the conditioned medium was
collected and centrifuged for 5 min at 600 × g. A 500-μl aliquot was concentrated to < 100 μl
in a Microcon concentrator at 14,000 × g at 4°C. Protein concentration was determined using
a commercial assay (Bio-Rad, Hercules, CA), and 1 μg of total protein (6–10 μl) from each
sample was electrophoresed on a 10% zymography gel containing 0.1% gelatin (Novex, San
Diego, CA). MMP-9 activity was detected by incubating the gel in 1× zymogram renaturing
buffer for 30 min at room temperature and then in 1× zymogram developing buffer (Novex)
overnight at 37 °C, followed by staining with GelCode Blue (Pierce Corp., Rockford, IL). After
staining, the bands were quantified using Bio-Rad Gel Doc 2000™ Systems with Bio-Rad TDS
Quantity One software.
Establishing malignant transformation
To test their ability to form tumors, the chronic arsenic-treated and passage-matched control
HaCaT cells were inoculated bilaterally into the renal capsules (2 million cells/kidney capsule/
animal) of male nude mice (NCr-nu, n = 11). Mice were obtained at 8 weeks of age from the
NCI-Frederick Animal Production Area and were housed in an American Association for
Accreditation of Laboratory Animal Care (AAALAC) accredited facility under conditions that
met or exceeded recommendations outlined in the Guide for Care and Use of Laboratory
Animals (National Institutes of Health Publication No. 86–23, 2985). The study proposal was
approved by the Institutional Animal Care and Use Committee. Tumor formation was assessed
biweekly. The first tumor was detected 10 weeks after injection of arsenic-treated cells and the
average sacrifice time for the mice in this group was 150 days. Controls were sacrificed when
the last mouse inoculated with arsenic-treated cells was sacrificed. Kidneys and any resulting
tumors were embedded in paraffin, sectioned, stained with H&E, and analyzed by light
microscopy.
Acute cytotoxicity assay
A minimum of 5 replicates of 10,000 cells per well were plated in 96-well plates and allowed
to adhere to the plate for 24 hrs, at which time the media was removed and replaced with fresh
serum-free media containing arsenic compounds. Cells were then incubated for an additional
24 hrs and cell viability and cytotoxicity was determined using Non-Radioactive Cell-
Proliferation Assay Kit (Promega, Madison, WI) and CytoTox96 Non-Radioactive
Cytotoxicity Assay Kit (Promega), respectively.
Determination of apoptosis by flow cytometry
Cells were seeded in 6-wells plate and grown to ~80% confluence. 18 hrs post UVB exposure
the cells, including floating and attached cells, were harvested for apoptosis analysis. Detection
of phosphatidylserine on the outer leaflet of apoptotic cells was performed using TACS
Annexin V-FITC Apoptosis Detection Kit (Trevigen, Gaithersburg, MD) detailed previously
[10]. For each sample, 10,000 cells were examined by flow cytometry using a Becton Dickinson
FACSort (Becton Dickinson, San Jose, CA). The percent of apoptotic cells was determined by
statistical analysis of the various dot plots using CellQuest software.
Preparation of protein extracts and western blotting
The whole cell extracts were obtained by using Cell Lysis Buffer (Cell Signaling Technology,
Inc., Beverly, MA) with 0.5% of Protease Inhibitor Cocktail (Sigma) and 1% of Phosphatase
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Inhibitor Cocktail I (Sigma). Nuclear and cytosolic fractions were separated by TransFactor
Extraction Kit (BD Biosciences Clontech, Palo Alto, CA). All the protein fractions were stored
at −70 °C until use. Proteins were separated by Novex 4–12% or 4–20% Tris-Glycine Gel
(Invitrogen) and transferred onto nitrocellulose membranes. The blots were probed with the
primary antibodies followed by incubation with horseradish peroxidase-conjugated secondary
antibodies. Antibody incubations were performed in Blocker™ BLOTTO in TBS (Pierce,
Rockford, IL). Immunoreactive proteins were detected by chemiluminescence using ECL
reagent (Amersham Pharmacia, Piscataway, NJ) and subsequent autoradiography. Antibodies
for Nrf2 (sc-13032), keratin-10 (sc-6258), involucrin (sc-15223), HO-1 (sc-1797), NQO1
(sc-16464), CK2α (sc-9030), CK2α′ (sc-6481), and CK2β (sc-12739) were purchased from
Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Antibodies for caspase-3 (#9661), caspase-7
(#9491); PARP (#9541) and β-actin (#4967) were from Cell Signaling.
Measurement of CK2 activity
The activity of CK2 in nuclear fractions was determined using Casein Kinase 2 Assay Kit
(Upstate, Lake Placid, NY). Briefly, nuclear fraction (30 μg protein) was incubated with CK2
substrate peptide (200 μM) in CK2 buffer (pH 7.2) containing 20 mM MOPS, 25 mM β-
glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM dithiothreitol, 25 mM
magnesium chloride, 100 μM ATP, 0.2 mM substrate peptide, 0.4 μM PKA inhibitor cocktail,
and 100 μCi of [γ-32P]ATP (PerkinElmer Life Sciences, Inc., Boston, MA) for 30 min at 37 °
C. After the reaction was stopped by adding 20 μl of 40% trichloroacetic acid, a 25 μl aliquot
was transferred to a P81 paper square, and the radiolabeled substrate was allowed to bind to
the paper for 30 s. The paper squares were rinsed three times with 30 ml of 0.75% phosphoric
acid each and followed by a 5-min washing with 20 ml of acetone. Dried squares were
transferred to scintillation vial filled with 5 ml of scintillation cocktail (ICN Biomedicals Inc.,
Costa Mesa, CA) and read in LS 6500 Multi-Purpose Scintillation Counter (Beckman Coulter,
Fullerton, CA).
Quantitative real-time RT–PCR analysis
Total RNA was isolated by using TRIzol (Invitrogen), and then subjected to DNase I digestion
using RNase-Free DNase Set (Qiagen, Valencia, CA), followed by cleanup with RNeasy Mini
kit (Qiagen). RNA from each sample was reverse transcribed with MuLV reverse transcriptase
(Applied Biosystems, Foster City, CA) and Oligo d(T) primers. The SYBR Green PCR Kit
(Applied Biosystems) was used for quantitative real-time RT-PCR analysis. The primers
(Table S1, Online materials) were designed using Primer Express software (Applied
Biosystems). Relative differences in gene expression between groups were expressed using
cycle time values; these values were first normalized with that of β-actin in the same sample,
and the expression in the experimental group was expressed as folds of controls. Real time
fluorescence detection was carried out using a MyiQ™ SingleColor Real-Time PCR Detection
System (Bio-Rad, Hercules, CA).
Statistics
All statistical analyses were performed using Graphpad Prism 4 (GraphPad Software, San
Diego, CA), with p < 0.05 taken as significant. For comparisons between As-TM and control
cells, Students’ t test were performed. Statistical analyses to evaluate the acute effect of arsenite
on Nrf2 protein levels as well as the time- and dose-dependent effects of arsenite or tBHQ
exposure on gene expression between As-TM and control cells were performed using two-way
ANOVA with Bonferroni post hoc testing. A Fischer’s exact test was used to examine
differences in tumor incidence after inoculation of control or As-TM cells into nude mice.
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Low level, chronic arsenic treatment of HaCaT cells induces malignant transformation
To achieve oncogenic transformation, HaCaT cells were continuously exposed to a low level
(100 nM) of inorganic arsenite. The arsenic concentration used in this study is comparable to
human blood arsenic levels found in chronic arsenosis patients in Inner Mongolia, China, where
arsenic-induced skin lesions and cancers are common [22]. After 28 weeks of continuous
arsenic exposure, the arsenic-treated cells exhibited unique morphological alterations with the
frequent occurrence of giant multinuclear cells (Fig. 1A), which are common during malignant
transformation and in tumors [23]. In addition, a marked increase in secretion of active MMP-9,
but not MMP-2, from arsenic-treated cells occurred (Fig. 1B). Extracellular MMP-9 activity
was 2.3-fold higher in arsenic-treated cells compared to control. Furthermore, As-TM cells
expressed dramatically higher expression levels of keratin-1, keratin-10, involucrin and
loricrin, markers of keratinocyte differentiation and skin keratinization, compared to control
cells (Fig. 1C and 1D). Malignant transformation was confirmed when the arsenic-treated cells
produced aggressive cancers after inoculation into nude mice, and these cells are henceforth
termed As-TM to designate the acquisition. Within 20 weeks of inoculation, 5/11 mice
inoculated with the As-TM cells developed tumors (P = 0.035) compared to 0/11 mice
inoculated with the control HaCaT cells. Histologic examination revealed the tumors to be
highly aggressive squamous cell carcinoma (SCC), showing clear evidence of invasion into
the renal parenchyma (Fig. 1E). Thus, based on variety of criteria, it is clear that the As-TM
cells have acquired a highly malignant phenotype that duplicates a common form of skin cancer
in arsenic-exposed humans [1].
As-TM cells resistant to arsenic cytotoxicity and UVB-induced apoptosis
Our previous data [10] indicated that HaCaT cells chronically treated with arsenic show
resistance to apoptosis induced by high concentrations of arsenite or UVA. Here, a generalized
resistance to arsenic cytotoxicity is also observed in As-TM cells. When As-TM and control
cells were exposed to different concentrations of arsenite (Fig. 2A and 2C) or inorganic arsenate
(Fig. 2B) for 24 hrs, assays of metabolic integrity (Fig. 2A and 2B) as well as lactate
dehydrogenase (LDH) release (Fig. 2C) revealed a dramatic difference in cytotoxicity between
the two cell lines. Since methylation is a primary metabolic process of arsenic in vivo and also
is involved in arsenic toxicity and carcinogenetic effect, the methylation activity was evaluated
in As-TM and control cells. Surprisingly, no arsenic methylation activity was detected in both
As-TM and control cells (Online material Fig. S1). Thus, whatever the basis of toxicity in this
case the agent is likely not a methylated arsenical.
To examine whether the As-TM cells acquired apoptotic resistance to UVB, a potent human
dermal carcinogen, As-TM and control cells were exposed to environmental exposure-relevant
doses of UVB radiation (25 mJ/cm2). At 18 hr after cells were exposed to UVB, general cell
damage and apoptosis was determined by microscopy examination and flow cytometry,
respectively. As shown in Fig. 2D, a significantly lower portion of As-TM cells (32%) vs.
control cells (81%) showed morphological changes including shrinkage or floating. Consistent
with this microscopy observation, 35.4% of the control cells underwent apoptosis after UVB
exposure, whereas only 18.8% of the As-TM cells were apoptotic (Fig. 2E). These results were
supported by caspase-3, caspase-7 and PARP analysis. Western blot analysis indicated that the
As-TM cells exhibited much less activated caspase-3, caspase-7 and PARP than control cells
after high UVB exposure (Fig. 2F). These data, together with our previous findings [10],
indicate As-TM cells acquired generalized apoptotic resistance.
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As-TM cells show increased CK2 expression and nuclear activity
Our recent results [24] provided evidence that endogenous human Nrf2 is constitutively
phosphorylated and that casein kinase-2 (CK2) is the major kinase responsible for the
phosphorylation, which is critical in regulating the Nrf2-mediated cellular antioxidant
response. CK2 is composed of two catalytic subunits (α and α′ assembled as αα, α′ α′ or αα′),
and a dimer of two regulatory β subunits [25]. As shown in Fig. 3A, the As-TM cells showed
enhanced CK2 expression, including α, α′, and β subunits when compared to control.
Furthermore, the nuclear protein levels of CK2 catalytic subunits α and α′ (Fig. 3B), as well
as CK2 specific activity in nuclear fractions (Fig. 3C) were significantly higher in As-TM cells
than in control cells.
As-TM cells exhibit enhanced antioxidant levels and weakened Nrf2-mediated antioxidant
response
Since oxidative damage has been recognized as a possible mode of action of arsenic
carcinogenesis [9,26], levels of intracellular GSH and its oxidized form (GSSG) were measured
in As-TM and control cells. GSH, synthesized by GCL and glutathione synthetase, is the most
important, as well as abundant, redox buffer in cells [27]. In its reaction to scavenge peroxides,
GSH is converted by oxidation to GSSG, which can subsequently be reduced back to GSH by
glutathione reductase. The balance between GSH and GSSG has long been recognized as an
important indicator of oxidative stress [27]. As shown in Fig. S2A (Online materials),
intracellular GSH levels of As-TM cells are slightly, but statistically higher than that of control
cells. Along with this, Fig. S2B illustrates the dramatic increase in GSSG levels in the As-TM
cells, suggesting a chronic oxidative stress occurred in these cells. Consistent with the results
that As-TM cells contain elevated levels of GSH and GSSG, the gene expression of GCLC
and its key regulatory nuclear factor Nrf2 is significantly increased in the cells (Fig. 4 A and
4C). In addition, without acute stress challenge the mRNA levels of NQO1 and HO-1, both
Nrf2 targets, are also significantly higher in As-TM cells than controls (Fig. 4 C).
Our previous data indicated that two phosphorylated forms of endogenous Nrf2 accumulate in
the nucleus after chemically-induced oxidative stress including acute arsenite exposure [24].
CK2-mediated sequential phosphorylation, resulting in Nrf2-98 with transcriptional activity
and Nrf2-118 causing Nrf2 degradation, plays a critical role in Nrf2 activation and degradation
[24]. Consistent with the findings that As-TM cells acquired increased nuclear CK2 activity
(Fig. 3C) and the regulatory roles of CK2 on Nrf2 phosphorylation [24], As-TM cells showed
a higher ratio of the form Nrf2-118 to Nrf2-98 after the cells were acutely exposed to arsenite
at a dose (10 μM, 2–6 hrs) which can induce Nrf2 activation (Fig. 4B). In particular, the
Nrf2-98, with transcriptional activity, was much lower in As-TM than in control cells under
the same acute treatment conditions (Fig. 4B). Importantly, in As-TM cells the increases in the
Nrf2-target genes, including NQO1, HO-1 and GCLC, induced by acute arsenite or tert-
butylhydroquinone (tBHQ) treatment were significantly lower than control cells (Fig. 4B).
Furthermore, compared to control cells a dramatic decrease in protein levels of HO-1 induced
by acute arsenite challenge was observed in As-TM cells (Fig. 4D).
Discussion
Low-level, chronic arsenic exposure can induce malignant transformation in various human
and rodent cells [28–32]. In the present study when HaCaT cells were continuously exposed
to environmentally relevant levels of arsenic for a protracted period, malignant transformation
occurred as evidenced by the formation of highly aggressive SCC, a common form of skin
cancer in arsenic-exposed humans [1], after inoculation of nude mice. Importantly, by studying
this cell model system several important biomarkers for arsenic-induced malignant
transformation, including increased secretion of MMP-9, expression profile of Nrf2-target
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genes and cytokeratins, acquired apoptotic resistance and decreased Nrf2-mediated antioxidant
response, were indentified.
MMPs are a family of matrix-degrading enzymes that play a critical role in invasion and
metastasis of malignant tumors and hypersecretion of MMPs is common in highly aggressive
tumors [33]. MMP-9 specifically targets type IV collagen, a major component of basement
membrane, and appears to play a crucial role in tumor invasion across the basement membrane
[34]. Elevated expression levels of MMP-9 are strongly correlated with malignant phenotype
in SCC [34] and are characteristic of malignant transformation of cells [29]. In human
keratinocyes constitutive production and secretion of MMP-9 correlate with the degree of
tumorigenicity in malignantly transformed clones [33]. Thus, the dramatically increased
secretion of MMP-9 observed in As-TM cells might be an important biomarker for arsenic-
induced malignant transformation in human keratinocytes. It is noteworthy that the promoter
region of MMP-9 gene contains multiple highly conserved AREs [35], suggesting Nrf2 may
act as a direct transcriptional regulator of MMP-9.
Skin hyperkeratosis is common in chronic arsenosis [22]. Importantly, SCC can arise from
arsenic-induced hyperkeratotic lesions [36], suggesting dysfunctional keratinization may be
critical in arsenic-induced skin carcinogenesis. In the current study, As-TM cells were observed
to exhibit dramatically increased expression levels of keratin-1, keratin-10, involucrin, and
loricrin, major markers of squamous differentiation that play important roles in skin
keratinization [37]. Since aberrant over-expressions of these markers have been observed in
skin hyperkeratosis [38,39], skin SCC [40], bladder SCC [41] and lung cancer [42], the
enhanced expressions observed in As-TM cells may represent additional indicators for arsenic-
induced malignant transformation. Interestingly, emerging data suggests that Nrf2 may act as
a direct transcriptional regulator of certain squamous differentiation genes through their
respective AREs [43]. Thus, the enhanced expression of these genes and marked increase in
secretion of active MMP-9 observed in As-TM cells might be a consequence of chronic Nrf2
activation. It should be noted that the expression of keratin-10 in As-TM cells is different from
what was observed in higher concentrations of arsenite-induced malignant transformation of
keratinocyte [30].
CK2 is a ubiquitous and highly conserved pleiotropic serine/threonine protein kinase, and it
appears to function predominantly in regulating the activities of nuclear proteins, including the
regulation of cell growth and proliferation, as well as cell survival [25,44]. Dysregulation of
CK2 expression imparts a potent oncogenic potential to cells and overexpression of CK2 is
often a key factor in carcinogenic transformation [45]. A consistent elevation of CK2 has been
observed in rapidly proliferating tissues and a wide variety of tumors [46]. In the present study,
increased expression and activity of CK2 was observed in As-TM cells, suggesting increase
in CK2 might be a critical event during the process of arsenic-induced malignant transformation
of human keratinocytes.
Apoptosis normally functions to control the integrity of cell populations by eliminating aberrant
clones, whereas failure of apoptosis likely is a key contributor to tumor initiation and
progression as well as drug resistance in skin cancer and cancer in general [47,48]. Thus, the
acquired, generalized apoptotic resistance in As-TM cells may be an important event in the
process of arsenic-induced malignant transformation. Our previous studies have indicated that
arsenic-induced apoptotic resistance is potentially associated with PI3K/PKB-mediated
cellular survival signaling pathways [10]. In the present study, increased levels of CK2, which
participates in inhibition of apoptosis and negatively regulates caspase activity in tumor cells
[49], was observed. This finding suggests the enhanced CK2 expression of As-TM cells might
be involved in their acquired apoptotic resistance.
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In contrast to increased expression of Nrf2 and its target genes, including GCLC as well as
elevated levels of intracellular GSH, a weakened Nrf2-mediated antioxidant response was
observed in As-TM cells. The decrease of Nrf2 activation in response to high levels of oxidative
stressors observed in As-TM cells, coupled with their acquired apoptotic resistance might
increase the likelihood to acquire heritable oxidative DNA damage [7,9]. This may help explain
the remarkable co-carcinogenic effects of arsenic and UV irradiation observed in mouse models
of dermal carcinogenesis but the absence of activity for arsenic alone [3,4]. Our previous study
indicated that exogenous GSH might markedly suppress hypochlorous acid-induced Nrf2
activation in mouse macrophages [50], suggesting the enhanced GSH levels in As-TM cells
might be a critical factor for the weakened Nrf2 activation. In addition, increased activities of
Nrf2 downstream phase II enzymes in As-TM cells might detoxify both arsenic and tBHQ,
and thus results in decreased Nrf2 activation. Furthermore, our recent studies revealed that
CK2 is an important protein kinase for Nrf2 phosphorylation, which is involved in Nrf2
activation and degradation [24]. The enhanced activity of CK2 and subsequent Nrf2
phosphorylation of As-TM cells might also contribute to their decreased Nrf2-medicated
antioxidant response.
In summary, long-term arsenic exposure at levels in the range of human exposure causes
malignant transformation of human keratinocytes in vitro. This occurs concurrently with
acquired apoptotic resistance, increased expression of CK2, elevated basal Nrf2 activity, and
decreased Nrf2-mediated antioxidant response. Arsenic-induced apoptotic resistance and
weakened antioxidant response may be critical steps in development of dermal cancer after
exposure to the metalloid.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Low-level, chronic arsenic exposure induces malignant transformation in HaCaT cells. (A)
Morphological alterations in arsenic-exposed cells. Images were taken by a microscope with
a Polarold camera (200 × magnification) (left) and a laser scanning confocal microscope (LSM
510 NLO) after the cells were stained with propidium iodide (right). Arrows indicate giant
multinuclear cells. (B) Analysis of MMP-9 secretion from As-TM and passage-matched
control cells. Changes in MMP-9 activity were quantified by densitometric analysis of the
bands. n = 3. *, p < 0.05 vs. control cells. (C–D) Increased expression of keratin-1, keratin-10,
involucrin and loricrin in As-TM cells. Gene expression and protein levels were determined
using real-time RT-PCR (C) and Western blot (D), respectively. Lower panel of (D) is the
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quantified results of Western blots. n = 3 – 4. *, p < 0.05 vs. control cells. (E) Histologic
examination of tumors formed by As-TM cells after inoculation into the renal capsules of male
nude mice. 20 weeks after inoculation, the tumors were removed, fixed in formalin, embedded
in paraffin, sectioned, and stained with H&E. The staining pattern revealed the tumors to be
aggressive squamous cell carcinoma. Arrows indicate giant multinuclear cells.
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As-TM cells acquired generalized apoptotic resistance. (A–C) As-TM cells resistant to
cytotoxicity induced by inorganic arsenicals. After one-week arsenic-free cultivation, cells
were seeded into 96-well plates (10000 cells/well) and grown to 80% confluence at which time
the indicated concentrations of arsenicals including arsenite (A and C) and arsenate (B) were
added. Cytotoxicity was assessed 24 hrs later by metabolic integrity MTS assay (A–B) and
LDH release (absorbance at 490 nm) (C). Results are presented as the mean ± SEM, n = 6.
Results of MTS assay expressed as percent of untreated control of appropriate cells, which are
set at 100%. (D–F) As-TM cells resistant to apoptosis induced by UVB. (D) 18 hr after cells
were exposed to UVB (25 mJ/cm2), images were taken by a microscope with a Polarold camera.
(E) Percentage of total apoptosis calculated based on the measurements of flow cytometry. n
= 4. *, p < 0.05 vs. control cells with UVB. (F) Immunoblotting of cleaved caspase-3 and 7
and PARP in As-TM and control cells. C, control; TM, As-TM cells.
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As-TM cells exhibit increased CK2 expression and activity. (A) Gene expression of CK2
subunits in As-TM and controls. (B) Protein levels of CK2 subunits in nuclear fractions
extracted from As-TM and controls. Lower panel, quantified results of the Western blot results.
(C) CK2 activity in nuclear fractions extracted from As-TM and control cells. *, p < 0.05 vs.
control cells.
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As-TM cells show enhanced basal Nrf2 activity and weakened Nrf2-mediated antioxidant
response. (A) Gene expression of Nrf2 in As-TM cells. n = 3–6. *, p < 0.05 vs. control. (B)
Representative images of Nrf2 immunoblots with nuclear fractions (upper) and quantitative
results (middle and lower). *, p < 0.05 vs. exposure- and time-matched control cells. C, control;
TM, As-TM cells. (C) Real-time RT-PCR analysis of expression of Nrf2-target genes. Data
are shown as folds of the control cells without acute treatment. *, p < 0.05 vs. exposure- and
time-matched control cells. (D) Protein levels of HO-1 in As-TM and control cells acutely
exposed to arsenite. C, control cells; TM, As-TM cells. *, p < 0.05 vs. exposure-and time-
matched control cells.
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